VF
SRRA

Virtu Financial’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Virtu Financial’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,262
Closed -$344K – 2550
2022
Q2 		$344K Buy
+6,262
New +$329K 0.03% 525
2019
Q4 		$59K Buy
+4,273
New +$55.7K 0.01% 1183
2019
Q3 		– Sell
-2,996
Closed -$67K – 1981
2019
Q2 		$67K Buy
2,996
+2,530
+543% +$123K ﹤0.01% 1201
2019
Q1 		$32K Buy
+466
New +$29.9K ﹤0.01% 1256
2018
Q4 		– Sell
-344
Closed -$23K – 2120
2018
Q3 		$23K Sell
344
-973
-74% -$88.2K ﹤0.01% 1400
2018
Q2 		$156K Buy
1,317
+414
+46% +$41.5K 0.01% 1566
2018
Q1 		$75K Buy
903
+598
+196% +$67.8K ﹤0.01% 1637
2017
Q4 		$45K Buy
+305
New +$29.3K ﹤0.01% 2098

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Virtu Financial's SRRA Position: Q3 2022 in Review

Virtu Financial sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 6,262 shares — an estimated $344K sold.

Virtu Financial first reported a position in SRRA in Q4 2017 and held it in 8 quarters. The position peaked at $344K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Virtu Financial reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 6,262 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $344K.
  • Virtu Financial first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Virtu Financial's Sierra Oncology, Inc. Common Stock position peaked at $344K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.